Introduction {#S1}
============

Carbapenem-resistant *Klebsiella pneumoniae* (CRKP) is an increasing problem worldwide ([@B16]; [@B15]). Horizontal transfer of plasmid-mediated carbapenemase-encoding genes, especially the predominant *bla*~KPC~, is contributing to the dissemination of carbapenem resistance among CRKP ([@B33]). Unlike the *bla*~KPC~ gene, the IMP-type metallo-β-lactamase (MBL) genes, which have been reported carried by IncL/M, IncA/C, IncHI2, and IncN plasmids in Enterobacterales from Australia and China ([@B24]; [@B7]; [@B28]), were not frequently detected in CRKP and associated with IncFII~K~ plasmids ([@B26]). IMP-26, which differs from IMP-4 by a single amino acid substitution (Phe49Val), was firstly reported from the *Pseudomonas aeruginosa* isolate in Singapore in 2010 ([@B11]; [@B22]) and was demonstrated to possess increased carbapenem-hydrolyzing activity to meropenem than IMP-1 ([@B22]).

Tigecycline was considered to be the last-resort drug to treat infections caused by CRKP ([@B23]). However, the previously described *tet(*A) variant ([@B31]) and recently identified *tet*(X) variants, such as *tet*(X3), *tet*(X4), *tet*(X5), and *tet*(X6) ([@B10]; [@B21]; [@B25]; [@B13]), have been reported to mediate the low-level and high-level tigecycline resistance, respectively. Both *tet*(A) variant and *tet*(X) variants are mobilized, indicating that they are posing a higher threat to public health. The association between the tigecycline resistance genes and carbapenem-hydrolyzing enzymes genes in CRKP has not been well explored.

Herein, we characterized an IncFII~k~ plasmid co-carrying *bla*~IMP--26~ and tigecycline-resistant gene *tet*(A) variant in a clinical *K. pneumoniae* isolate which displayed resistance to carbapenems and tigecycline.

Materials and Methods {#S2}
=====================

Bacterial Isolation, Antimicrobial Susceptibility Testing, and PCR Detection {#S2.SS1}
----------------------------------------------------------------------------

*Klebsiella pneumonia* KP-1572 was obtained from a sputum culture of a 1-day newborn boy hospitalized due to intracranial hemorrhage associated with neonatal infections at a teaching hospital of the Zhengzhou University.

The MICs to imipenem, meropenem, aztreonam, ceftazidime, gentamicin, amikacin, tetracycline, tigecycline, colistin, and fosfomycin were determined using the broth microdilution method and the agar dilution method (for fosfomycin) according to the Clinical and Laboratory Standards Institute guidelines (CLSI) ([@B5]) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST)^[1](#footnote1){ref-type="fn"}^. *Escherichia coli* ATCC 25922 served as the quality-control strain.

PCR was used to determine the presence of the carbapenem-resistance and tigecycline-resistance genes *bla*~KPC~, *bla*~NDM~, *bla*~IMP~, *bla*~VIM~, *bla*~OXA,~ *tet*(A), and *tet*(X4) with primers described previously ([@B17]; [@B31]; [@B10]).

Multilocus Sequence Typing {#S2.SS2}
--------------------------

Multilocus sequence typing (MLST) of *K. pneumoniae* KP-1572 were performed as described previously ([@B6]). PCR amplification and sequencing for seven housekeeping genes (*gapA*, *infB*, *mdh*, *pgi*, *phoE*, *rpoB*, and *tonB*) were carried out. Then, the sequences of these seven housekeeping genes were submitted to a database^[2](#footnote2){ref-type="fn"}^ to obtain the ST type.

S1-PFGE and Southern Blotting {#S2.SS3}
-----------------------------

S1-PFGE and Southern blotting were performed to detect the location of the resistance genes. The whole-cell DNA of the *K. pneumonia* KP-1572 isolate in agarose gel plug was treated with S1 nuclease (TaKaRa, Dalian, China) and then separated by PFGE under the conditions reported previously ([@B18]). The location of the *bla*~IMP--26~ and *tet*(A) variant was indicated by Southern hybridization using a digoxigenin-labeled *bla*~IMP~ and *tet*(A) probe, respectively, according to the manufacturer's instructions for the DIG-High Prime DNA Labeling and Detection Starter Kit II (Roche Diagnostics, Basel, Switzerland).

Conjugation Assay and Electrotransformation Experiments {#S2.SS4}
-------------------------------------------------------

Conjugation assays were performed according to the method described previously with minor modification ([@B3]). Briefly, the rifampicin-resistant *E. coli* isolate EC600 was used as the recipient, and donor and recipient strains were mixed at a ratio of 1:4 on LB agar and cultured for 12 h. The mixtures were collected and then plated on an LB agar containing rifampicin (64 μg/mL) and meropenem (1 μg/mL) or tigecycline (0.5 μg/mL). Electrotransformation was performed as described previously ([@B30]). Briefly, the plasmid co-harboring the *bla*~IMP--26~ and *tet*(A) variant was extracted from *K. pneumoniae* KP-1572 and then transferred into the recipient Electro-Cells *E. coli* DH5α (TaKaRa, Dalian, China) by electroporation (Bio-Rad MicroPulser, 1.8 kV, 5 ms). The electrotransformants were screened by LB agar containing meropenem (1 μg/mL).

Plasmid Sequencing and Analysis {#S2.SS5}
-------------------------------

The plasmid was sequenced by the PacBio RS and Illumina MiSeq platforms (Shanghai Personal Biotechnology Co., Ltd., China). The PacBio sequence reads were assembled with HGAP4 and CANU (Version 1.6) and corrected by Illumina MiSeq with Pilon (Version 1.22). The prediction and annotation of ORFs were performed using Glimmer 3.0.

Results and Discussion {#S3}
======================

*Klebsiella pneumoniae* KP-1572 exhibited a multiple drug resistance (MDR) profile for a wide range of antimicrobial agents, including imipenem, meropenem, aztreonam, ceftazidime, gentamicin, tetracycline, tigecycline, and colistin, while it was susceptible to amikacin and fosfomycin ([Table 1](#T1){ref-type="table"}). Resistance gene screening and sequencing revealed that *K. pneumonia* KP-1572 co-carried the carbapenem-resistance gene *bla*~IMP--26~ variant and tigecycline-resistance gene *tet*(A) variant. The *tet*(A) variant showed a mutation profile of I5R, V55M, I75V, T84A, S201A, F202S, and V203F compared with *tet*(A) (X00006) ([@B29]) and exhibited 100% identity with that in our previous study ([@B31]). Multilocus sequence typing (MLST) showed that *K. pneumonia* KP-1572 belonged to uncommon sequence type ST1083, which was reported in carbapenem*-*resistant *K. pneumonia* isolated from clinical bovine mastitis in Tunisia ([@B19]).

###### 

Antibiotic susceptibility of KP-1572 isolate and its electrotransformant.

  Isolate   Antibiotic susceptibility (μg/ml) to                                                                    
  --------- -------------------------------------- -------- -------- ------ ------ ----- -------- -------- -------- -----
  KP-1572   64                                     \>64     64       \>64   64     8     \>64     2        8        8
  DKP1572   16                                     16       8        64     32     1     \>64     2        0.5      \<1
  DH5α      \<0.25                                 \<0.25   \<0.25   0.5    0.25   0.5   \<0.25   \<0.25   \<0.25   \<1

a

IPM, imipenem; MEM, meropenem; ATM, aztreonam; CAZ, ceftazidime; GN, gentamicin; AK, amikacin; TET, tetracycline; TIG, tigecycline; CL, colistin; FOS, fosfomycin.

S1 nuclease PFGE and Southern blotting confirmed that the gene *bla*~IMP--26~ and *tet*(A) variant were located on an identical plasmid of KP-1572 ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). The conjugation experiments failed after three attempts; however, transformants were successfully obtained by electroporation, which was confirmed by PCR and S1-PFGE ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). The susceptibility testing results indicated that the electrotransformant (designed DKP1572) showed \> 64-fold increased resistance to meropenem and imipenem compared to the recipient DH5α. DKP1572 also exhibited an increased resistance level (2 μg/mL, eightfold increase) to tigecycline than that of DH5α ([Table 1](#T1){ref-type="table"}).

Whole-plasmid sequencing of plasmid in DKP1572 (named pIMP1572) showed that it is an IncFII~k~-type plasmid with a length of 142,993 bp and an average GC content of 53.5%, which encodes 117 predicted open reading frames. The plasmid pIMP1572 consisted of an 89,521-bp IncFII~K~ typical backbone encoding genes responsible for plasmid replication, transfer, and stability functions, and a 53,472-bp variable region ([Figure 1](#F1){ref-type="fig"}). The oriTs, relaxases, T4SS gene clusters, and T4CPs are closely associated with conjugation of plasmids ([@B12]); however, mutations were present in relaxases, TraB, TraD, and T4CP encoding genes in pIMP1572, which might explain the failure of its conjugation. pIMP1572 is a multiple-drug-resistance plasmid that included the aminoglycoside resistance genes *aac*(3)-IId, *aadA16*, and *aac*(6′)*-Ib-cr*; β-lactam resistance genes *bla*~TEM--1B~, *bla*~CTX--M--15~, and *bla*~TEM--1C~; macrolide resistance gene *mph*(A); rifampicin resistance gene *arr-3*, sulfonamide resistance gene *sul1*; and trimethoprim resistance gene *dfrA27* in addition to the *bla*~IMP--26~ and *tet*(A) variant ([Figure 1](#F1){ref-type="fig"}). Multiple transfer elements, such as IS*26*, were also present in this plasmid ([Figure 1](#F1){ref-type="fig"}), which may promote the dissemination of resistance genes among *K. pneumoniae* and other Enterobacterales.

![The structure of the plasmid pIMP1572 from *K. pneumonia* KP-1572. The size scale in bp; genes are color-coded, depending on functional annotations: red, antimicrobial resistance; blue, plasmid transfer; green, plasmid replication; yellow, transposition; purple, other functions; and white, hypothetical proteins.](fmicb-11-01610-g001){#F1}

Analysis of the flanking regions of *bla*~IMP--26~ revealed that this gene was located in a class 1 integron cassette, *IntI1*-*bla*~IMP--26~-ORF1-*qacE*△*1-sul1*, which contained a complete 5′ conserved sequence (5′-CS, integrase *intl1*) and 3′-CS (*qacE*△*1-sul1*). The *bla*~IMP--26~-carrying class 1 integron cassette in this study showed 100% identity and 97% query coverage with the corresponding region of a plasmid pIMP26 in *Enterobacter cloacae* isolated from the bloodstream in China ([@B27]) but was different from that reported in *P. aeruginosa* in Vietnam ([@B22]). Tn*1721* was a member of Tn*3*-family unit transposons, with the complete genetic structure of *mcp*-*res*-*tnpR*-*tnpA*-*tetR*-*tet*(A)-*pecM*-Δ*tnpA* ([@B1]). In this study, the *tet*(A) variant was found in a truncated Tn*1721*-like transposon with arrangement of the Δ*tnpA*-relaxase-*tetR*-*tet*(A) variant ([Figure 1](#F1){ref-type="fig"}). Recently, the *tet*(A) variant was found located on a *bla*~KPC--2~-carrying plasmid in *K. pneumonia* and was confirmed to mediate tigecycline resistance ([@B31]; [@B32]). To our knowledge, the current study is the first time to report the presence of a *bla*~IMP--26~ and *tet*(A) variant-co-carrying plasmid, which can render *K. pneumonia* to be reduced susceptibility significantly to both carbapenems and tigecycline, posing a threat to treatments of CRKP infection in clinic.

The sequence data revealed that pIMP1572 shares 99.99% identity and 89% query coverage^[3](#footnote3){ref-type="fn"}^ with an IncFII~k~ type pKp21774-135 in *K. pneumoniae* (accession number in GenBank, [MG878868](MG878868)) ([Figure 2](#F2){ref-type="fig"}). Multiple drug resistance regions (MDRR) with a length of 25,259 bp insertion and 6,216 bp deletion were found in pIMP1572 plasmids in this study, when compared with pKp21774-135 ([Figure 2](#F2){ref-type="fig"}). The insertion MDRR that contained multiple resistance genes was bracketed by IS*26*, including *qacE*△*1-sul1*, *bla*~TEM--1~, *aac*(3)-IId, and *mph*(A) in addition to *bla*~IMP--26~. The sequence of the MDRR region showed 99% identity and query coverage to the corresponding region of an IncA/C2 plasmid pCf52 (KY887592) from *Citrobacter freundii* ([Figure 2](#F2){ref-type="fig"}), indicating that this MDRR may be acquired from *C. freundii* other than *K. pneumonia.*

![The structure comparison of the plasmid pIMP1572 identified in this study with others published previously. The gray-shaded areas represent genomic regions that share 99% nucleotide sequence identities.](fmicb-11-01610-g002){#F2}

IncFII~k~ plasmid, a member of the divergent IncFII replicon plasmids, played a significant role in restoring and transferring the *bla*~KPC~ gene in *K. pneumoniae* ([@B8]; [@B28]; [@B2]; [@B9]), which was also reported sporadically to carry MBL-encoding genes, such as *bla*~NDM~ ([@B20]). The plasmid pIMP1572 identified in this study is different from previously reported *bla*~IMP~-harboring plasmids that belonged to incompatibility groups IncL/M, A/C, HI2, and IncN ([@B4]; [@B7]; [@B28]) and represents the first report of IncFII~k~ plasmid carrying *bla*~IMP~. Association of *bla*~IMP~-like genes with an epidemic IncFII~k~ plasmid may facilitate their further dissemination among *K. pneumonia*. Thus, enhanced efforts should be made to monitor the potentially rapid dissemination of *bla*~IMP~ and *tet*(A) variant-encoding IncFII~k~-type plasmid.
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Detection of *bla*~IMP26--~ and *tet*(A) variant- co-carrying plasmid by S1-PFGE and Southern hybridization.
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